flecainide has been researched along with Adenoma in 1 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
Adenoma: A benign epithelial tumor with a glandular organization.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Chronic administration of flecainide did not produce chronic toxic changes in either species." | 1.27 | Chronic oral toxicity and oncogenicity studies of flecainide, an antiarrhythmic, in rats and mice. ( Case, MT; Sibinski, LJ; Steffen, GR, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Case, MT | 1 |
| Sibinski, LJ | 1 |
| Steffen, GR | 1 |
1 other study available for flecainide and Adenoma
| Article | Year |
|---|---|
Chronic oral toxicity and oncogenicity studies of flecainide, an antiarrhythmic, in rats and mice.
Topics: Adenoma; Administration, Oral; Animals; Anti-Arrhythmia Agents; Body Weight; Carcinogens; Dose-Respo | 1984 |